| Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ... Science 375 (6576), 43-50, 2022 | 915 | 2022 |
| Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial A Osinusi, EG Meissner, YJ Lee, D Bon, L Heytens, A Nelson, M Sneller, ... Jama 310 (8), 804-811, 2013 | 399 | 2013 |
| Cross-linkable polymers based on dialkylfluorenes G Klärner, JI Lee, VY Lee, E Chan, JP Chen, A Nelson, D Markiewicz, ... Chemistry of materials 11 (7), 1800-1805, 1999 | 306 | 1999 |
| Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection A Osinusi, K Townsend, A Kohli, A Nelson, C Seamon, EG Meissner, ... Jama 313 (12), 1232-1239, 2015 | 260 | 2015 |
| Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study A Kohli, R Kapoor, Z Sims, A Nelson, S Sidharthan, B Lam, R Silk, C Kotb, ... The Lancet Infectious Diseases 15 (9), 1049-1054, 2015 | 224 | 2015 |
| Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study A Kohli, A Osinusi, Z Sims, A Nelson, EG Meissner, LL Barrett, D Bon, ... The Lancet 385 (9973), 1107-1113, 2015 | 181 | 2015 |
| Abnormal B cell memory subsets dominate HIV-specific responses in infected individuals L Kardava, S Moir, N Shah, W Wang, R Wilson, CM Buckner, BH Santich, ... The Journal of clinical investigation 124 (7), 3252-3262, 2014 | 145 | 2014 |
| Effect of Histone Deacetylase Inhibitors on HIV Production in Latently Infected, Resting CD4+ T Cells From Infected Individuals Receiving Effective Antiretroviral … J Blazkova, TW Chun, BW Belay, D Murray, JS Justement, EK Funk, ... The Journal of infectious diseases 206 (5), 765-769, 2012 | 120 | 2012 |
| Paucity of HIV DNA Methylation in Latently Infected, Resting CD4+ T Cells from Infected Individuals Receiving Antiretroviral Therapy J Blazkova, D Murray, JS Justement, EK Funk, AK Nelson, S Moir, ... Journal of virology 86 (9), 5390-5392, 2012 | 114 | 2012 |
| Utility of hepatitis C viral load monitoring on direct-acting antiviral therapy S Sidharthan, A Kohli, Z Sims, A Nelson, A Osinusi, H Masur, S Kottilil Clinical Infectious Diseases 60 (12), 1743-1751, 2015 | 107 | 2015 |
| Predicting scheduled hospital attendance with artificial intelligence A Nelson, D Herron, G Rees, P Nachev NPJ digital medicine 2 (1), 26, 2019 | 100 | 2019 |
| Re-treatment of chronic hepatitis C virus genotype 1 infection after relapse: an open-label pilot study A Osinusi, A Kohli, MM Marti, A Nelson, X Zhang, EG Meissner, R Silk, ... Annals of internal medicine 161 (9), 634-638, 2014 | 100 | 2014 |
| All Oral Treatment for Genotype 4 Chronic Hepatitis C Infection with Sofosbuvir and Ledipasvir: Interim Results from the NIAID SYNERGY Trial: 240 R Kapoor, A Kohli, S Sidharthan, Z Sims, TL Petersen, A Osinusi, ... Hepatology 60, 321A, 2014 | 81 | 2014 |
| Characterization of plasmablasts in the blood of HIV-infected viremic individuals: evidence for nonspecific immune activation CM Buckner, S Moir, J Ho, W Wang, JG Posada, L Kardava, EK Funk, ... Journal of virology 87 (10), 5800-5811, 2013 | 81 | 2013 |
| High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study T Petersen, K Townsend, LA Gordon, S Sidharthan, R Silk, A Nelson, ... Hepatology international 10, 310-319, 2016 | 74 | 2016 |
| Four-week direct-acting antiviral regimens in noncirrhotic patients with hepatitis C virus genotype 1 infection: an open-label, nonrandomized trial A Kohli, S Kattakuzhy, S Sidharthan, A Nelson, M McLaughlin, C Seamon, ... Annals of internal medicine 163 (12), 899-907, 2015 | 66 | 2015 |
| A new method for detection of pfmdr1 mutations in Plasmodium falciparum DNA using real-time PCR A Purfield, A Nelson, A Laoboonchai, K Congpuong, P McDaniel, ... Malaria Journal 3, 1-6, 2004 | 61 | 2004 |
| Successful retreatment of chronic HCV genotype-1 infection with ledipasvir and sofosbuvir after initial short course therapy with direct-acting antiviral regimens EM Wilson, S Kattakuzhy, S Sidharthan, Z Sims, L Tang, M McLaughlin, ... Clinical Infectious Diseases 62 (3), 280-288, 2016 | 52 | 2016 |
| High Efficacy of Sofosbuvir/Ledipasvir for the Treatment of HCV Genotype 1 in Patients Coinfected With HIV on or off Antiretroviral therapy: Results from The NIAID ERADICATE … KS Townsend, A Osinusi, AK Nelson, A Kohli, C Gross, MA Polis, ... Hepatology 60, 240A-241A, 2014 | 45 | 2014 |
| The CD8+HLA‐DR+ T cells expanded in HIV‐1 infection are qualitatively identical to those from healthy controls H Imamichi, RA Lempicki, JW Adelsberger, RB Hasley, A Rosenberg, ... European journal of immunology 42 (10), 2608-2620, 2012 | 45 | 2012 |
